In vitro exposure of human fibroblasts to local anaesthetics impairs cell growth.
Lidocaine, bupivacaine or ropivacaine are used routinely to manage perioperative pain. Sparse data exist evaluating the effects of local anaesthetics (LA) on fibroblasts, which are involved actively in wound healing. Therefore, we investigated the effects of the three LA to assess the survival, viability and proliferation rate of fibroblasts. Human fibroblasts were exposed to 0·3 mg/ml and 0·6 mg/ml of each LA for 2 days, followed by incubation with normal medium for another 1, 4 or 7 days (group 1). Alternatively, cells were incubated permanently with LA for 3, 6 or 9 days (group 2). Live cell count was assessed using trypan blue staining. Viability was measured by the tetrazolium bromide assay. Proliferation tests were performed with the help of the colorimetric bromodeoxyuridine assay. Production of reactive oxygen species (ROS) was determined, measuring the oxidation of non-fluorescent-2,7'-dichlorofluorescin. Treatment of cells with the three LA showed a concentration-dependent decrease of live cells, mitochondrial activity and proliferation rate. Group arrangement played a significant role for cell count and proliferation, while exposure time influenced viability. Among the analysed LA, bupivacaine showed the most severe cytotoxic effects. Increased production of ROS correlated with decreased viability of fibroblasts in lidocaine- and bupivacaine-exposed cells, but not upon stimulation with ropivacaine. This study shows a concentration-dependent cytotoxic effect of lidocaine, bupivacaine and ropivacaine on fibroblasts in vitro, with more pronounced effects after continuous incubation. A possible mechanism of cell impairment could be triggered by production of ROS upon stimulation with lidocaine and bupivacaine.
Fedder
C
C
Department of Cranio-Maxillofacial Surgery, University Hospital of Zurich Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Switzerland.
Beck-Schimmer
B
B
Aguirre
J
J
Hasler
M
M
Roth-Z'graggen
B
B
Urner
M
M
Kalberer
S
S
Schlicker
A
A
Votta-Velis
G
G
Bonvini
J M
JM
Graetz
K
K
Borgeat
A
A
D000577:Amides / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002045:Bupivacaine / Q000494:pharmacology; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000378:metabolism; D000077212:Ropivacaine
D000577:Amides; D000779:Anesthetics, Local; D017382:Reactive Oxygen Species; D000077212:Ropivacaine; D008012:Lidocaine; D002045:Bupivacaine
Anesth Analg. 1980 Oct;59(10):727-36
7191645
Curr Opin Anaesthesiol. 2005 Oct;18(5):522-6
16534287
Arthroscopy. 2006 Aug;22(8):813-9
16904576
Cell Prolif. 1991 Sep;24(5):517-23
1932360
Agents Actions. 1993 Sep;40(1-2):78-85
8147273
Reg Anesth Pain Med. 2004 Jul-Aug;29(4):333-40
15305253
Am J Sports Med. 2008 Aug;36(8):1484-8
18658020
Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3029-33
1399407
Am J Sports Med. 2007 Oct;35(10):1621-7
17664340
J Shoulder Elbow Surg. 2009 Sep-Oct;18(5):742-7
19186080
J Clin Anesth. 2000 Dec;12(8):595-9
11172999
Br J Anaesth. 1979 Apr;51(4):273-81
465252
Anesth Analg. 2008 Nov;107(5):1592-7
18931217
Anesthesiology. 2007 Sep;107(3):461-8
17721249
Anesth Analg. 2002 Feb;94(2):385-8, table of contents
11812704
Anesth Analg. 2005 Aug;101(2):548-554
16037174
Acta Anaesthesiol Scand. 1959;3(2):59-73
13660633
Arthroscopy. 2006 Jul;22(7):693-9
16843803
Science. 1982 Oct 29;218(4571):474-5
7123245
J Bone Miner Res. 1993 Jun;8(6):651-7
8328306
Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3B
18432654
Anesthesiology. 1999 Mar;90(3):835-43
10078686
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
J Bone Joint Surg Am. 2008 May;90(5):986-91
18451389
Arthroscopy. 2005 Mar;21(3):313-6
15756185
J Dent Res. 2005 Sep;84(9):852-7
16109997
Anesth Analg. 2006 Jul;103(1):229-33, table of contents
16790658
Retina. 2000;20(5):478-82
11039422
Best Pract Res Clin Anaesthesiol. 2003 Mar;17(1):111-36
12751552
Acta Anaesthesiol Scand. 2008 Feb;52(2):262-6
17999712
Anesthesiology. 2005 Nov;103(5):1035-45
16249678
Anesth Analg. 2009 Mar;108(3):997-1007
19224816
Am J Physiol Cell Physiol. 2004 Oct;287(4):C817-33
15355853
Br J Anaesth. 2003 Feb;90(2):189-93
12538376
Br J Anaesth. 2008 Dec;101(6):832-40
18945716
Exp Neurol. 1972 Feb;34(2):264-78
5016199
Anesthesiology. 2002 Sep;97(3):710-6
12218539
Anesthesiology. 2008 Aug;109(2):180-7
18648226
Eur J Pharmacol. 2009 Jun 24;613(1-3):68-73
19394327
Acta Biomed. 2008 Aug;79(2):92-105
18788503
Anesthesiology. 2005 Apr;102(4):793-8
15791109
Surg Infect (Larchmt). 2008 Apr;9(2):205-13
18426354
Reg Anesth Pain Med. 2008 Jan-Feb;33(1):4-9
18155050
Arch Toxicol. 1991;65(5):351-60
1929850
Toxicol Appl Pharmacol. 2004 Jan 15;194(2):101-10
14736491
J Dent Res. 2010 Apr;89(4):372-7
20164497
Anesth Analg. 1983 Nov;62(11):995-1001
6625219
Hepatology. 1993 Nov;18(5):1154-61
8225222
Acta Anaesthesiol Scand. 2007 Jan;51(1):108-14
17073856
Anesthesiology. 2006 May;104(5):961-9
16645448